Protein | Synonyms | Taxonomy |
Nucleoside diphosphate kinase, mitochondrial | NDK; NDP kinase, mitochondrial; EC 2.7.4.6; Nucleoside diphosphate kinase D; NDPKD; nm23-H4 | Homo sapiens (human) |
Adenylosuccinate synthetase isozyme 2 | AMPSase 2; AdSS 2; EC 6.3.4.4; Adenylosuccinate synthetase, acidic isozyme; Adenylosuccinate synthetase, liver isozyme; L-type adenylosuccinate synthetase; IMP--aspartate ligase 2 | Homo sapiens (human) |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | EC 3.1.4.35 | Homo sapiens (human) |
Pyruvate kinase PKM | EC 2.7.1.40; Cytosolic thyroid hormone-binding protein; CTHBP; Opa-interacting protein 3; OIP-3; Pyruvate kinase 2/3; Pyruvate kinase muscle isozyme; Thyroid hormone-binding protein 1; THBP1; Tumor M2-PK; p58 | Homo sapiens (human) |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | GMP-PDE alpha; EC 3.1.4.35; PDE V-B1 | Homo sapiens (human) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | EC 3.1.4.53; DPDE2; PDE46 | Homo sapiens (human) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | EC 3.1.4.53; DPDE4; PDE32 | Homo sapiens (human) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | EC 3.1.4.53; DPDE3; PDE43 | Homo sapiens (human) |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | EC 3.1.4.17; Cyclic GMP-inhibited phosphodiesterase A; CGI-PDE A | Homo sapiens (human) |
Atrial natriuretic peptide receptor 2 | EC 4.6.1.2; Atrial natriuretic peptide receptor type B; ANP-B; ANPR-B; NPR-B; Guanylate cyclase B; GC-B | Homo sapiens (human) |
AMP deaminase 2 | EC 3.5.4.6; AMP deaminase isoform L | Homo sapiens (human) |
Adenylate cyclase type 9 | EC 4.6.1.1; ATP pyrophosphate-lyase 9; Adenylate cyclase type IX; ACIX; Adenylyl cyclase 9; AC9 | Homo sapiens (human) |
Atrial natriuretic peptide receptor 1 | EC 4.6.1.2; Atrial natriuretic peptide receptor type A; ANP-A; ANPR-A; NPR-A; Guanylate cyclase A; GC-A | Homo sapiens (human) |
Multifunctional protein ADE2 | | Homo sapiens (human) |
GMP synthase [glutamine-hydrolyzing] | EC 6.3.5.2; GMP synthetase; Glutamine amidotransferase | Homo sapiens (human) |
cGMP-dependent 3',5'-cyclic phosphodiesterase | EC 3.1.4.17; Cyclic GMP-stimulated phosphodiesterase; CGS-PDE; cGSPDE | Homo sapiens (human) |
cGMP-specific 3',5'-cyclic phosphodiesterase | EC 3.1.4.35; cGMP-binding cGMP-specific phosphodiesterase; CGB-PDE | Homo sapiens (human) |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | HsPDE8B; EC 3.1.4.53; Cell proliferation-inducing gene 22 protein | Homo sapiens (human) |
Hypoxanthine-guanine phosphoribosyltransferase | HGPRT; HGPRTase; EC 2.4.2.8 | Homo sapiens (human) |
Inosine-5'-monophosphate dehydrogenase 2 | IMP dehydrogenase 2; IMPD 2; IMPDH 2; EC 1.1.1.205; IMPDH-II | Homo sapiens (human) |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | GMP-PDE gamma; EC 3.1.4.35 | Homo sapiens (human) |
Pyruvate kinase PKLR | EC 2.7.1.40; Pyruvate kinase 1; Pyruvate kinase isozymes L/R; R-type/L-type pyruvate kinase; Red cell/liver pyruvate kinase | Homo sapiens (human) |
Xanthine dehydrogenase/oxidase | | Homo sapiens (human) |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Cam-PDE 1A; EC 3.1.4.17; 61 kDa Cam-PDE; hCam-1 | Homo sapiens (human) |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Cam-PDE 1B; EC 3.1.4.17; 63 kDa Cam-PDE | Homo sapiens (human) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | EC 3.1.4.53; DPDE1; PDE21 | Homo sapiens (human) |
Adenylate cyclase type 1 | EC 4.6.1.1; ATP pyrophosphate-lyase 1; Adenylate cyclase type I; Adenylyl cyclase 1; Ca(2+)/calmodulin-activated adenylyl cyclase | Homo sapiens (human) |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | EC 3.1.4.17; CGIPDE1; CGIP1; Cyclic GMP-inhibited phosphodiesterase B; CGI-PDE B | Homo sapiens (human) |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | EC 3.1.4.17; EC 3.1.4.35 | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 2 | NTPDase 2; EC 3.6.1.-; CD39 antigen-like 1; Ecto-ATP diphosphohydrolase 2; Ecto-ATPDase 2; Ecto-ATPase 2 | Homo sapiens (human) |
Phosphoribosylformylglycinamidine synthase | FGAM synthase; FGAMS; EC 6.3.5.3; Formylglycinamide ribonucleotide amidotransferase; FGAR amidotransferase; FGAR-AT; Formylglycinamide ribotide amidotransferase | Homo sapiens (human) |
Cytosolic purine 5'-nucleotidase | EC 3.1.3.5; Cytosolic 5'-nucleotidase II | Homo sapiens (human) |
Amidophosphoribosyltransferase | ATase; EC 2.4.2.14; Glutamine phosphoribosylpyrophosphate amidotransferase; GPAT | Homo sapiens (human) |
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | PAPS synthase 2; PAPSS 2; Sulfurylase kinase 2; SK 2; SK2 | Homo sapiens (human) |
Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] | EC 3.6.1.17; Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase; Ap4A hydrolase; Ap4Aase; Diadenosine tetraphosphatase; Nucleoside diphosphate-linked moiety X motif 2; Nudix motif 2 | Homo sapiens (human) |
5'(3')-deoxyribonucleotidase, mitochondrial | 5',3'-nucleotidase, mitochondrial; EC 3.1.3.-; Deoxy-5'-nucleotidase 2; dNT-2 | Homo sapiens (human) |
Adenylate kinase 4, mitochondrial | AK 4; EC 2.7.4.10; EC 2.7.4.6; Adenylate kinase 3-like; GTP:AMP phosphotransferase AK4 | Homo sapiens (human) |
Guanylate kinase | EC 2.7.4.8; GMP kinase; Guanylate kinase 1 | Homo sapiens (human) |
Adenylate cyclase type 6 | EC 4.6.1.1; ATP pyrophosphate-lyase 6; Adenylate cyclase type VI; Adenylyl cyclase 6; Ca(2+)-inhibitable adenylyl cyclase | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 3 | NTPDase 3; EC 3.6.1.5; CD39 antigen-like 3; Ecto-ATP diphosphohydrolase 3; Ecto-ATPDase 3; Ecto-ATPase 3; Ecto-apyrase 3; HB6 | Homo sapiens (human) |
Adenylate cyclase type 5 | EC 4.6.1.1; ATP pyrophosphate-lyase 5; Adenylate cyclase type V; Adenylyl cyclase 5; AC5 | Homo sapiens (human) |
Nucleoside diphosphate kinase A | NDK A; NDP kinase A; EC 2.7.4.6; Granzyme A-activated DNase; GAAD; Metastasis inhibition factor nm23; NM23-H1; Tumor metastatic process-associated protein | Homo sapiens (human) |
Thymidine phosphorylase | TP; EC 2.4.2.4; Gliostatin; Platelet-derived endothelial cell growth factor; PD-ECGF; TdRPase | Homo sapiens (human) |
Inosine-5'-monophosphate dehydrogenase 1 | IMP dehydrogenase 1; IMPD 1; IMPDH 1; EC 1.1.1.205; IMPDH-I | Homo sapiens (human) |
Nucleoside diphosphate kinase B | NDK B; NDP kinase B; EC 2.7.4.6; C-myc purine-binding transcription factor PUF; Histidine protein kinase NDKB; 2.7.13.3; nm23-H2 | Homo sapiens (human) |
Ribonucleoside-diphosphate reductase large subunit | EC 1.17.4.1; Ribonucleoside-diphosphate reductase subunit M1; Ribonucleotide reductase large subunit | Homo sapiens (human) |
Ribonucleoside-diphosphate reductase subunit M2 | EC 1.17.4.1; Ribonucleotide reductase small chain; Ribonucleotide reductase small subunit | Homo sapiens (human) |
Bifunctional purine biosynthesis protein ATIC | AICAR transformylase/inosine monophosphate cyclohydrolase; ATIC | Homo sapiens (human) |
Adenylate cyclase type 8 | EC 4.6.1.1; ATP pyrophosphate-lyase 8; Adenylate cyclase type VIII; Adenylyl cyclase 8; AC8; Ca(2+)/calmodulin-activated adenylyl cyclase | Homo sapiens (human) |
Adenosine kinase | AK; EC 2.7.1.20; Adenosine 5'-phosphotransferase | Homo sapiens (human) |
Adenylate cyclase type 2 | EC 4.6.1.1; ATP pyrophosphate-lyase 2; Adenylate cyclase type II; Adenylyl cyclase 2 | Homo sapiens (human) |
Adenylate cyclase type 10 | EC 4.6.1.1; AH-related protein; Adenylate cyclase homolog; Germ cell soluble adenylyl cyclase; hsAC; sAC; Testicular soluble adenylyl cyclase | Homo sapiens (human) |
Guanine deaminase | Guanase; Guanine aminase; EC 3.5.4.3; Guanine aminohydrolase; GAH; p51-nedasin | Homo sapiens (human) |
Heat-stable enterotoxin receptor | STA receptor; hSTAR; EC 4.6.1.2; Guanylyl cyclase C; GC-C; Intestinal guanylate cyclase | Homo sapiens (human) |
AMP deaminase 3 | EC 3.5.4.6; AMP deaminase isoform E; Erythrocyte AMP deaminase | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 4 | NTPDase 4; EC 3.6.1.15; EC 3.6.1.6; Golgi UDPase; Lysosomal apyrase-like protein of 70 kDa; Uridine-diphosphatase; UDPase; 3.6.1.42 | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 5 | NTPDase 5; EC 3.6.1.6; CD39 antigen-like 4; ER-UDPase; Guanosine-diphosphatase ENTPD5; GDPase ENTPD5; 3.6.1.42; Nucleoside diphosphatase; Uridine-diphosphatase ENTPD5; UDPase ENTPD5 | Homo sapiens (human) |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | GMP-PDE delta; Protein p17 | Homo sapiens (human) |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | EC 3.1.4.53 | Homo sapiens (human) |
Purine nucleoside phosphorylase | PNP; EC 2.4.2.1; Inosine phosphorylase; Inosine-guanosine phosphorylase | Homo sapiens (human) |
Adenosine deaminase | EC 3.5.4.4; Adenosine aminohydrolase | Homo sapiens (human) |
5'-nucleotidase | 5'-NT; EC 3.1.3.5; Ecto-5'-nucleotidase | Homo sapiens (human) |
Trifunctional purine biosynthetic protein adenosine-3 | | Homo sapiens (human) |
AMP deaminase 1 | EC 3.5.4.6; AMP deaminase isoform M; Myoadenylate deaminase | Homo sapiens (human) |
Guanylate cyclase soluble subunit alpha-2 | GCS-alpha-2; EC 4.6.1.2 | Homo sapiens (human) |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | GMP-PDE beta; EC 3.1.4.35 | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 1 | NTPDase 1; EC 3.6.1.5; Ecto-ATP diphosphohydrolase 1; Ecto-ATPDase 1; Ecto-ATPase 1; Ecto-apyrase; Lymphoid cell activation antigen | Homo sapiens (human) |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | EC 3.1.4.35; cGMP phosphodiesterase 6C | Homo sapiens (human) |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | EC 3.1.4.53; HCP1; TM22 | Homo sapiens (human) |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | GMP-PDE gamma; EC 3.1.4.35 | Homo sapiens (human) |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Cam-PDE 1C; 3',5'-cyclic-AMP phosphodiesterase; 3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase; 3.1.4.35; Hcam3 | Homo sapiens (human) |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | EC 3.1.4.53 | Homo sapiens (human) |
Adenylate kinase isoenzyme 1 | AK 1; EC 2.7.4.3; EC 2.7.4.6; ATP-AMP transphosphorylase 1; ATP:AMP phosphotransferase; Adenylate monophosphate kinase; Myokinase | Homo sapiens (human) |
Adenylate cyclase type 7 | EC 4.6.1.1; ATP pyrophosphate-lyase 7; Adenylate cyclase type VII; Adenylyl cyclase 7 | Homo sapiens (human) |
Guanylate cyclase soluble subunit alpha-1 | GCS-alpha-1; EC 4.6.1.2; Guanylate cyclase soluble subunit alpha-3; GCS-alpha-3; Soluble guanylate cyclase large subunit | Homo sapiens (human) |
Adenylate cyclase type 4 | EC 4.6.1.1; ATP pyrophosphate-lyase 4; Adenylate cyclase type IV; Adenylyl cyclase 4 | Homo sapiens (human) |
ADP-ribose pyrophosphatase, mitochondrial | EC 3.6.1.13; ADP-ribose diphosphatase; ADP-ribose phosphohydrolase; Adenosine diphosphoribose pyrophosphatase; ADPR-PPase; Nucleoside diphosphate-linked moiety X motif 9; Nudix motif 9 | Homo sapiens (human) |
Adenylosuccinate synthetase isozyme 1 | AMPSase 1; AdSS 1; EC 6.3.4.4; Adenylosuccinate synthetase, basic isozyme; Adenylosuccinate synthetase, muscle isozyme; M-type adenylosuccinate synthetase; Adenylosuccinate synthetase-like 1; AdSSL1; IMP--aspartate ligase 1 | Homo sapiens (human) |
Adenylosuccinate lyase | ADSL; ASL; EC 4.3.2.2; Adenylosuccinase; ASase | Homo sapiens (human) |
Adenylate cyclase type 3 | EC 4.6.1.1; ATP pyrophosphate-lyase 3; Adenylate cyclase type III; AC-III; Adenylate cyclase, olfactive type; Adenylyl cyclase 3; AC3 | Homo sapiens (human) |
Guanylate cyclase soluble subunit beta-2 | GCS-beta-2; EC 4.6.1.2 | Homo sapiens (human) |
Adenylate kinase 2, mitochondrial | AK 2; EC 2.7.4.3; ATP-AMP transphosphorylase 2; ATP:AMP phosphotransferase; Adenylate monophosphate kinase | Homo sapiens (human) |
Guanylate cyclase soluble subunit beta-1 | GCS-beta-1; EC 4.6.1.2; Guanylate cyclase soluble subunit beta-3; GCS-beta-3; Soluble guanylate cyclase small subunit | Homo sapiens (human) |
5'(3')-deoxyribonucleotidase, cytosolic type | EC 3.1.3.-; Cytosolic 5',3'-pyrimidine nucleotidase; Deoxy-5'-nucleotidase 1; dNT-1 | Homo sapiens (human) |
Inosine triphosphate pyrophosphatase | ITPase; Inosine triphosphatase; EC 3.6.1.9; Non-canonical purine NTP pyrophosphatase; Non-standard purine NTP pyrophosphatase; Nucleoside-triphosphate diphosphatase; Nucleoside-triphosphate pyrophosphatase; NTPase; Putative oncogene protein hlc14-06-p | Homo sapiens (human) |
GMP reductase 2 | GMPR 2; EC 1.7.1.7; Guanosine 5'-monophosphate oxidoreductase 2; Guanosine monophosphate reductase 2 | Homo sapiens (human) |
ADP-sugar pyrophosphatase | EC 3.6.1.13; 8-oxo-dGDP phosphatase; 3.6.1.58; Nuclear ATP-synthesis protein NUDIX5; 2.7.7.96; Nucleoside diphosphate-linked moiety X motif 5; Nudix motif 5; hNUDT5; YSA1H | Homo sapiens (human) |
Adenine phosphoribosyltransferase | APRT; EC 2.4.2.7 | Homo sapiens (human) |
Retinal guanylyl cyclase 2 | RETGC-2; EC 4.6.1.2; Guanylate cyclase 2F, retinal; Guanylate cyclase F; GC-F; Rod outer segment membrane guanylate cyclase 2; ROS-GC2 | Homo sapiens (human) |
Retinal guanylyl cyclase 1 | RETGC-1; EC 4.6.1.2; CG-E; Guanylate cyclase 2D, retinal; Rod outer segment membrane guanylate cyclase; ROS-GC | Homo sapiens (human) |
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 | PAPS synthase 1; PAPSS 1; Sulfurylase kinase 1; SK 1; SK1 | Homo sapiens (human) |
Nucleoside diphosphate kinase 7 | NDK 7; NDP kinase 7; EC 2.7.4.6; nm23-H7 | Homo sapiens (human) |
GMP reductase 1 | GMPR 1; EC 1.7.1.7; Guanosine 5'-monophosphate oxidoreductase 1; Guanosine monophosphate reductase 1 | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 6 | NTPDase 6; EC 3.6.1.6; CD39 antigen-like 2 | Homo sapiens (human) |
Soluble calcium-activated nucleotidase 1 | SCAN-1; EC 3.6.1.6; Apyrase homolog; Putative MAPK-activating protein PM09; Putative NF-kappa-B-activating protein 107 | Homo sapiens (human) |
Nucleoside diphosphate kinase 6 | NDK 6; NDP kinase 6; EC 2.7.4.6; Inhibitor of p53-induced apoptosis-alpha; IPIA-alpha; nm23-H6 | Homo sapiens (human) |
Ribose-phosphate pyrophosphokinase 2 | EC 2.7.6.1; PPRibP; Phosphoribosyl pyrophosphate synthase II; PRS-II | Homo sapiens (human) |
Ribose-phosphate pyrophosphokinase 3 | EC 2.7.6.1; Phosphoribosyl pyrophosphate synthase 1-like 1; PRPS1-like 1; Phosphoribosyl pyrophosphate synthase III; PRS-III | Homo sapiens (human) |
Ribose-phosphate pyrophosphokinase 1 | EC 2.7.6.1; Phosphoribosyl pyrophosphate synthase I; PRS-I | Rattus norvegicus (Norway rat) |
Nucleoside diphosphate kinase homolog 5 | NDK-H 5; NDP kinase homolog 5; Inhibitor of p53-induced apoptosis-beta; IPIA-beta; Testis-specific nm23 homolog; nm23-H5 | Homo sapiens (human) |
Nucleoside diphosphate kinase 3 | NDK 3; NDP kinase 3; EC 2.7.4.6; DR-nm23; Nucleoside diphosphate kinase C; NDPKC; nm23-H3 | Homo sapiens (human) |
Probable allantoicase | EC 3.5.3.4; Allantoate amidinohydrolase | Homo sapiens (human) |
Cytosolic 5'-nucleotidase 1B | cN1B; EC 3.1.3.5; Autoimmune infertility-related protein; Cytosolic 5'-nucleotidase IB; cN-IB | Homo sapiens (human) |
Cytosolic 5'-nucleotidase 3A | EC 3.1.3.5; 7-methylguanosine phosphate-specific 5'-nucleotidase; 7-methylguanosine nucleotidase; 3.1.3.91; Cytosolic 5'-nucleotidase 3; Cytosolic 5'-nucleotidase III; cN-III; Pyrimidine 5'-nucleotidase 1; P5'N-1; P5N-1; PN-I; Uridine 5'-monophosphate hyd | Homo sapiens (human) |
Adenylate kinase isoenzyme 5 | AK 5; EC 2.7.4.3; EC 2.7.4.6; ATP-AMP transphosphorylase 5 | Homo sapiens (human) |
Compound | Description |
phosphoric acid | concise etchant is 37% H3PO4 |
diphosphoric acid | |
pyruvic acid | An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed) |
sulfuric acid | |
urea | A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. |
guanosine monophosphate | A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. |
adenine | A purine base and a fundamental unit of ADENINE NUCLEOTIDES. |
ammonium hydroxide | The hydroxy salt of ammonium ion. It is formed when AMMONIA reacts with water molecules in solution. |
Carbon Dioxide | A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. |
glutamic acid | A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. |
NADH | |
fumaric acid | see also record for ferrous fumarate; use FUMARATES for general fumaric acid esters |
Adenosine Triphosphate | An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. |
aspartic acid | One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. |
glutamine | A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. |
adenosine diphosphate | Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. |
adenosine monophosphate | Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. |
adenosine | A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. |
phosphoribosyl pyrophosphate | The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides. |
glycine | A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. |
Hydrogen Peroxide | A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. |
Water | A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) |
Oxygen | An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. |
diguanosine tetraphosphate | |
deoxyguanosine | A nucleoside consisting of the base guanine and the sugar deoxyribose. |
deoxyinosine | |
2'-deoxyguanosine 5'-phosphate | RN given refers to parent cpd. |
deoxyguanosine triphosphate | |
deoxyinosine monophosphate | |
2'-deoxyinosine triphosphate | can be used an an alternative for dGTP |
guanosine diphosphate | A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. |
guanosine triphosphate | Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. |
guanine | |
guanosine | A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed) |
inosinic acid | |
5,6,7,8-tetrahydrofolic acid | RN given refers to (DL)-isomer |
inosine diphosphate | An inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. |
cyclic gmp | Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) |
2'-deoxyguanosine 5'-phosphate | RN given refers to parent cpd. |
hypoxanthine | A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. |
inosine | A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed) |
inosine triphosphate | Inosine 5'-(tetrahydrogen triphosphate). An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: IRPPP. |
adenylosuccinate | |
phosphoribosyl-N-formylglycineamide | |
glycineamide ribonucleotide | structure |
phosphoenolpyruvate | A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways. |
uric acid | An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. |
2'-deoxy-5'-adenosine monophosphate | RN given refers to parent cpd |
2'-deoxyadenosine | was (MH) DEOXYADENOSINE (68-89) |
2'-deoxyadenosine triphosphate | RN given refers to unlabeled parent cpd |
2'-deoxyadenosine triphosphate | RN given refers to unlabeled parent cpd |
allantoic acid | RN given refers to parent cpd; structure |
xanthosine 5'-triphosphate | RN given refers to parent cpd |
2-deoxyribose 1-phosphate, (alpha-d-erythro)-isomer | |
NAD | A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) |
xanthosine | |
xanthosine 5'-triphosphate | RN given refers to parent cpd |
phosphoadenosine phosphosulfate | 3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. |
adenosine phosphosulfate | 5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS. |
xanthine | A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed) |
saicar | adenosylsuccinase catalyzes its conversion to AICAR |
aminoimidazole ribotide | |
carboxyaminoimidazole ribotide | reacts with alanosine to form antimetabolite; substrate for EC 4.1.1.21; structure in second source |
5-formamidoimidazole-4-carboxamide ribotide | purine precursor |
creolin | from refined coal tar oils |
Cyclic AMP | An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. |
aica ribonucleotide | purine precursor that has antineoplastic activity |
aminoimidazole carboxamide | An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. |